Antipsychotic Agents: all 1,814 studies that test it

Page 3 of 19. Open to participants first (97), then studies with results posted, then the rest; newest registration first within each.

• A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)CompletedNCT02694328Phase 3Results posted
• Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 4)TerminatedNCT02691182Phase 3Results posted
• Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I DepressionCompletedNCT02670551Phase 3Results posted
• Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I DisorderCompletedNCT02670538Phase 3Results posted
• A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With SchizophreniaCompletedNCT02669758Phase 3Results posted
• Thorough QT Study of Intravenous AmisulprideCompletedNCT02661594Phase 1Results posted
• Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane ImplantCompletedNCT02658357Phase 2Results posted
• Study of APD421 as PONV Treatment (Prior Prophylaxis)CompletedNCT02646566Phase 3Results posted
• Utility of Olanzapine in the Treatment of Opioid Withdrawal in the EDCompletedNCT02643355Not applicableResults posted
• Study of FOND Versus FOND+O for the Prevention of CINV in Hematology Patients Receiving Highly Emetogenic Chemotherapy RegimensCompletedNCT02635984Phase 3Results posted
• A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With SchizophreniaCompletedNCT02634320Phase 4Results posted
• Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) ProphylaxisCompletedNCT02625181Not applicableResults posted
• Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2)CompletedNCT02618434Phase 3Results posted
• Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 1)CompletedNCT02618408Phase 3Results posted
• The Effects of Antipsychotic Drugs on Brain Metabolism in Healthy IndividualsCompletedNCT02536846Phase 4Results posted
• Aprepitant ,Olanzapine,Palonosetron and Dexamethasone for the Prevention of Chemotherapy-induced Nausea and VomitingCompletedNCT02484911Phase 3Results posted
• Aripiprazole, Abilify Maintena Collaborative Clinical ProtocolTerminatedNCT02472652Phase 4Results posted
• A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass SpectrometryTerminatedNCT02462473Phase 2Results posted
• Study of APD421 as PONV Treatment (no Prior Prophylaxis)CompletedNCT02449291Phase 3Results posted
• A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic SchizophreniaTerminatedNCT02435836Phase 3Results posted
• A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or SchizophreniformCompletedNCT02431702Phase 3Results posted
• Iloperidone in Mixed States of Bipolar DisorderCompletedNCT02413918Phase 4Results posted
• BEEP Follow Up: Evaluation of Repeatability of Lamotrigine Pharmacokinetics in Epileptic PatientsCompletedNCT02404168Phase 4Results posted
• Biomarker and Safety Study of Clozapine in Patients With Benign Ethnic Neutropenia (BEN)CompletedNCT02404155Not applicableResults posted
• Hydromorphone Versus Prochlorperazine + Diphenhydramine for Acute MigraineCompletedNCT02389829Phase 4Results posted
• 16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar DepressionTerminatedNCT02389712Phase 4Results posted
• Study to Evaluate the Effects of Switching Different Strength Forms of FK949E in Bipolar Disorder Patients With Major Depressive EpisodesCompletedNCT02362412Phase 3Results posted
• Fluoxetine vs Aripiprazole Comparative Trial (FACT)TerminatedNCT02357849Phase 4Results posted
• Phase IIIb Study of APD421 in Combination as PONV ProphylaxisCompletedNCT02337062Phase 3Results posted
• Biosignatures of Latuda for Bipolar DepressionCompletedNCT02239094Not applicableResults posted
• A Multicenter Open-label Study Investigating the Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration by Injection Into the Deltoid Muscle in Patients With SchizophreniaCompletedNCT02220712Phase 1Results posted
• Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or ThoracotomyCompletedNCT02213900Phase 4Results posted
• D1 and D2 Dopamine Receptors in Gambling and Amphetamine ReinforcementCompletedNCT02203786Phase 2Results posted
• Lurasidone Effects on Tissue Glutamate in SchizophreniaCompletedNCT02199743Phase 4Results posted
• Pharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human SubjectsCompletedNCT02174523Phase 1Results posted
• A Pharmacokinetic Study of Lurasidone After Single Oral Administration in Healthy SubjectsCompletedNCT02174510Phase 1Results posted
• A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use DisorderCompletedNCT02161718Phase 2Results posted
• Study of Lamotrigine to Treat Ménière's DiseaseCompletedNCT02158585Phase 2Results posted
• Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility StudyCompletedNCT02129478Phase 2Results posted
• Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal ActivityCompletedNCT02118610Not applicableResults posted
• Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic ChemotherapyCompletedNCT02116530Phase 3Results posted
• Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 YearsCompletedNCT02102698Phase 2Results posted
• Pilot Study of Olanzapine and Aprepitant to Prevent Nausea and Vomiting in Children Receiving ChemotherapyCompletedNCT02097823Phase 2Results posted
• Substudy of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)CompletedNCT02091882Phase 4Results posted
• Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I DisorderTerminatedNCT02075047Phase 3Results posted
• Haloperidol vs Conventional Therapy for GastroparesisTerminatedNCT02057549Phase 4Results posted
• Efficacy of Quetiapine for Pediatric DeliriumTerminatedNCT02056171Phase 1/2Results posted
• Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute SchizophreniaCompletedNCT02054702Phase 3Results posted
• Lurasidone Pediatric Bipolar StudyCompletedNCT02046369Phase 3Results posted
• A Study of the Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease PsychosisCompletedNCT02035553Phase 2Results posted
• A Clinical Trial of Lurasidone in Treatment of SchizophreniaCompletedNCT02002832Phase 3Results posted
• Lamotrigine BioequivalenceCompletedNCT01995825Phase 4Results posted
• US Phase III Study of APD421 in PONVCompletedNCT01991860Phase 3Results posted
• European Phase III Study of APD421 in PONVCompletedNCT01991821Phase 3Results posted
• A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder.CompletedNCT01986114Phase 3Results posted
• A Phase III Study of SM-13496 in Patients With Bipolar I Depression.CompletedNCT01986101Phase 3Results posted
• Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the TreatCompletedNCT01971203Not applicableResults posted
• Aripiprazole Once-monthly in Patients With SchizophreniaCompletedNCT01959035Phase 3Results posted
• A Short Treatment Study of Aripiprazole in Pediatric Patients With SchizophreniaCompletedNCT01942161Phase 2/3Results posted
• A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With SchizophreniaCompletedNCT01942148Phase 3Results posted
• Acute D2 Receptor Blockade Induced Neuronal Network Changes in Human VolunteersCompletedNCT01931059Not applicableResults posted
• Assessing the Effects of Fanapt® on Social Cognition in SchizophreniaTerminatedNCT01929889Phase 4Results posted
• Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or PlaceboCompletedNCT01920802Phase 4Results posted
• Iloperidone for Symptoms of Arousal in Post Traumatic Stress Disorder (PTSD)TerminatedNCT01917318Phase 2Results posted
• Pediatric Open-Label Extension StudyCompletedNCT01914393Phase 3Results posted
• Lurasidone Pediatric Autism StudyCompletedNCT01911442Phase 3Results posted
• Pediatric Schizophrenia Efficacy and Safety StudyCompletedNCT01911429Phase 3Results posted
• Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With SchizophreniaCompletedNCT01909466Phase 1Results posted
• An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)CompletedNCT01895452Phase 3Results posted
• Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE)TerminatedNCT01891890Phase 3Results posted
• PET and MRI Brain Imaging of Bipolar DisorderCompletedNCT01880957Not applicableResults posted
• ADASUVE-Lorazepam Drug-Drug InteractionCompletedNCT01877642Phase 4Results posted
• A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM DepotCompletedNCT01870999Phase 1Results posted
• An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective DisordersCompletedNCT01855074Phase 4Results posted
• ADASUVE 2-dose Thorough QT/QTc StudyCompletedNCT01854710Phase 4Results posted
• 1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight GainTerminatedNCT01844700Phase 4Results posted
• Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive DisorderCompletedNCT01838876Phase 3Results posted
• Lurasidone Low-Dose - High-Dose Study StudyCompletedNCT01821378Phase 3Results posted
• Feasibility of Thioridazine as a Mobilizing Agent for CD34+ Hematopoietic Progenitor CellsTerminatedNCT01765803Early Phase 1Results posted
• Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan DiseaseTerminatedNCT01751802Phase 3Results posted
• Long-term Study of FK949E in Elderly Bipolar Disorder PatientsCompletedNCT01737268Phase 3Results posted
• Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and AdolescentsCompletedNCT01731119Phase 2Results posted
• Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's DisorderCompletedNCT01727713Phase 3Results posted
• Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's DisorderCompletedNCT01727700Phase 3Results posted
• A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive EpisodesCompletedNCT01725308Phase 2/3Results posted
• Study to Evaluate the Effect and Safety of Quetiapine Extended Release (XR) (FK949E) in Major Depressive DisorderCompletedNCT01725282Phase 2Results posted
• Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Patients With SchizophreniaCompletedNCT01724359Phase 4Results posted
• Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)CompletedNCT01715805Phase 3Results posted
• Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I DisorderCompletedNCT01710709Phase 3Results posted
• An Investigation of Early Life Stress and DepressionCompletedNCT01701258Phase 1Results posted
• Quetiapine Pharmacotherapy for Cannabis DependenceCompletedNCT01697709Phase 2Results posted
• A Study of Olanzapine and Fluoxetine for Treatment-resistant DepressionTerminatedNCT01687478Phase 3Results posted
• Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With SchizophreniaCompletedNCT01683058Phase 3Results posted
• Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/EfficacyCompletedNCT01677377Phase 2Results posted
• Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for DepressionCompletedNCT01670019Phase 4Results posted
• Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With SchizophreniaCompletedNCT01663532Phase 3Results posted
• Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With SchizophreniaCompletedNCT01662648Phase 3Results posted
• An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With SchizophreniaCompletedNCT01662310Phase 3Results posted
• Comparison of Quetiapine and Trazodone Treatment for Insomnia in Dually Diagnosed VeteransTerminatedNCT01662297Phase 4Results posted
• A Study to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mgCompletedNCT01654601Phase 1Results posted

← Antipsychotic Agents overview